Dr. Adanna Osei

Saying no to a feasibility assessment is a service, not a failure.

Every site we turn down feels, in the moment, like a missed opportunity for the practice and for us. But a site that enrolls slowly, generates protocol deviations, or fails an audit doesn't just hurt that one study — it follows the practice into every future feasibility conversation with that sponsor. We'd rather deliver an honest no early than an optimistic yes that costs a practice its research reputation.

Derek Novak

Recruitment plans fail when they're generic.

A flyer in a waiting room reaches whoever happens to be sitting there that week, which is rarely the same as the population a protocol actually needs. The recruitment plans that work start with chart review against the specific inclusion criteria, then build referral pathways through the physicians who already see those patients regularly. It's slower to set up than an ad campaign and finishes faster.

Simone Ekwueme

A delegation log is the most boring document that will save a site.

The delegation of authority log — who on staff is authorized to perform which study-related task — sounds like pure paperwork until an FDA inspection or a sponsor audit asks for it. Sites that treat it as a formality to fill in later almost always have it wrong when someone finally checks. We update ours the day a role changes, not the week before a monitoring visit.

Alexis Sandoval

Most data queries are a documentation problem, not a data problem.

When a sponsor's monitor flags a discrepancy, the underlying clinical fact is usually correct — what's missing is the source documentation connecting it back to the patient's chart. We catch the large majority of these internally before a monitoring visit simply by asking, for every entry, whether a stranger could trace it back to its source without asking anyone a question.

Considering a trial for your practice, or evaluating sites for a study? Get in touch — that's usually how the first conversation starts.